Regeneron Invest Advisor

Analyst Lowers Price Target for Regeneron Pharmaceuticals Amid Sales Concerns and Investor Lawsuit Feb 14, 2025

Cantor Fitzgerald Adjusts Earnings Forecast for Regeneron Pharmaceuticals Jan 22, 2025

Dupixent® (dupilumab) Gains Approval in China as Groundbreaking Biologic for COPD Patients Sep 28, 2024